Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Gossamer Bio, Inc. Director's Dealing 2023

Dec 5, 2023

32603_dirs_2023-12-05_97e01ec0-7900-4a57-94a2-b434ded46eb1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Gossamer Bio, Inc. (GOSS)
CIK: 0001728117
Period of Report: 2023-12-04

Reporting Person: Smith Robert Paul JR (Chief Commercial Officer)

More from Gossamer Bio, Inc.

Proxy Solicitation & Information Statement 2026
May 18
Regulatory Filings 2026
May 18
Interim / Quarterly Report 2026
May 15
Annual Report 2026
Apr 24
Proxy Solicitation & Information Statement 2026
Apr 24
Regulatory Filings 2026
Apr 9
Major Shareholding Notification 2026
Mar 27
Major Shareholding Notification 2026
Mar 24
Director's Dealing 2026
Mar 20
Director's Dealing 2026
Mar 20
View all filings →